PSU banks are poised for continued growth, with market participants confident the rally is far from over despite near-term challenges. Valuations remain attractive, and improved asset quality and comfortable capital adequacy are expected to drive outperformance against private lenders. Investors are advised to remain selective and monitor macro and stock-specific developments.
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.